Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 90/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
P 4 (1)

Trial Status

Recruiting1
Unknown1
Not Yet Recruiting1
Terminated1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07491094Not Yet Recruiting

Repeated Examinations for Typing Pulmonary Embolism

NCT03988842Phase 4TerminatedPrimary

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism

NCT04879069RecruitingPrimary

Polish Multicenter PERTs PE Outcomes Registry

NCT04473560UnknownPrimary

Catheter-directed Thrombectomy in High and Intermediate-high Risk Pulmonary Embolism

Showing all 4 trials

Research Network

Activity Timeline